(Q84958568)
Statements
Effectiveness at 1 year of monthly versus variable-dosing intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to age-related macular degeneration (English)
Gabriel Katz
Louis Giavedoni
Rajeev Muni
Teodoro Evans
Matthew Pezda
David Wong
Ashley Moffat
Shelley Boyd
1 February 2012